Skip to main content

Table 1 Patients characteristics – from chart review

From: Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States

Variable

Level

N

Mean

SD

Age at data extraction or death

 

178

65.83

9.35

Age at initial BC diagnosis

 

178

61.49

9.69

Age at progression to metastatic disease

 

178

62.85

9.39

   

n

%

Stage at diagnosis

Early (Stage IA, IB, IIA, IIB)

 

40

22.5%

 

Limited Regional (Stage IIIA)

 

8

4.5%

 

Locally Advanced (Stage IIIB)

 

6

3.4%

 

Locally Advanced (Stage IIIC)

 

5

2.8%

 

Metastatic (Stage IV)

 

119

66.9%

ECOG performance status at the time of diagnosis of mBCa

0

 

63

35.4%

1

 

96

53.9%

2

 

18

10.1%

3

 

1

0.6%

Adjuvant treatment received (history)

Yes

 

65

36.5%

No

 

111

62.4%

Don’t know

 

2

1.1%

  1. BC breast cancer; ECOG: Easter Cooperative Oncology Group; mBC: metastatic breast cancer
  2. aDefinition of ECOG performance statuses; 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work; 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3: Capable of only limited self-care, confined to bed or chair more than 50% of walking hours